{{Rsnum
|rsid=1949733
|Chromosome=4
|position=8501632
|Orientation=plus
|GMAF=0.2984
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=TRMT44
|Gene_s=TRMT44
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.7 | 38.9 | 51.3
| HCB | 17.5 | 48.2 | 34.3
| JPT | 17.9 | 54.5 | 27.7
| YRI | 0.7 | 17.0 | 82.3
| ASW | 3.5 | 29.8 | 66.7
| CHB | 17.5 | 48.2 | 34.3
| CHD | 14.7 | 43.1 | 42.2
| GIH | 1.0 | 30.7 | 68.3
| LWK | 0.9 | 17.3 | 81.8
| MEX | 25.9 | 39.7 | 34.5
| MKK | 3.8 | 35.3 | 60.9
| TSI | 13.7 | 33.3 | 52.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21659360
|Trait=None
|Title=Association between SNP-genotype and chronic lymphocytic leukemia outcome in a randomized chemotherapy trial.
|RiskAllele=A
|Pval=8E-7
|OR=2.3600
|ORtxt=[1.60-3.47]
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}